The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis
Sign Up to like & getrecommendations! Published in 2023 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2023.2208347
Abstract: ABSTRACT Introduction Multiple sclerosis is a chronic, demyelinating, inflammatory, and neurodegenerative disease of the central nervous system that affects over 2 million people worldwide. Considerable advances have been made in the availability of disease modifying… read more here.
Keywords: highly effective; escalation versus; treatment; effective treatment ... See more keywords